Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of the COBIN open-label, cluster randomised trial

被引:0
|
作者
Thapa, Rajshree [1 ,2 ,3 ]
Zengin, Ayse [1 ]
Neupane, Dinesh [3 ,4 ]
Mishra, Shiva Raj [3 ,5 ]
Koirala, Sweta [3 ]
Kallestrup, Per [6 ]
Thrift, Amanda G. [1 ]
机构
[1] Monash Univ, Sch Clin Sci, Dept Med, Monash Hlth, Melbourne, Vic 3800, Australia
[2] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic, Australia
[3] Nepal Dev Soc, Chitwan, Bagmati Provinc, Nepal
[4] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Dept Epidemiol, Baltimore, MD USA
[5] Univ Melbourne, Sch Populat & Global Hlth, Epidemiol & Simulat Modelling, Melbourne, Vic, Australia
[6] Aarhus Univ, Ctr Global Hlth, Dept Publ Hlth, Aarhus, Midtjylland, Denmark
来源
LANCET GLOBAL HEALTH | 2023年 / 11卷 / 07期
关键词
DIABETES PREVENTION; HYPERTENSION; MANAGEMENT; WEIGHT; RISK; HOME;
D O I
10.1016/s2214-109x(23)00214-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background The sustainability and scalability of limited-duration interventions in low-income and middle-income countries remain unclear. We aimed to investigate the sustainability in reduction of blood pressure through a 12-month lifestyle intervention led by community health workers to reduce blood pressure in Nepal, 4 years after the intervention ceased. Methods The Community-Based Intervention for Control of Hypertension in Nepal (COBIN) trial was a non-blinded, cluster-randomised trial done in Kaski, Nepal. Adults aged 25-65 years were eligible. People were excluded if they declined consent, were severely ill, unlikely to be in the community throughout the intervention, or pregnant. During the 12-month intervention, female community health volunteers (FCHVs) visited participants in the intervention groups and provided lifestyle counselling and blood pressure measurement every 4 months. At the end of the 12-month intervention, systolic blood pressure was significantly lower in the intervention group than in the usual care group in all cohorts, ranging from -2 center dot 3 mm Hg (95% CI -3 center dot 8 to -0 center dot 8) lower in those with normal blood pressure to -4 center dot 9 mm Hg (-7 center dot 8 to -2 center dot 0) in the hypertensive cohort. The primary outcome for this follow-up study was a mean change in systolic blood pressure from baseline to follow-up at 60 months. We did an intention- to-treat analysis. Findings Between April 1, 2015, and Dec 31, 2015, 1638 participants were recruited in COBIN (939 [57 center dot 3%] assigned to intervention and 699 [42 center dot 7%] assigned to usual care). Of the 1468 (89 center dot 6%) who completed the 12-month assessments, we followed up 1352 (92 center dot 1%) participants at 60 months, between Oct 11, 2020, and May 5, 2022. 964 (71 center dot 3%) participants were women and 388 (28 center dot 7%) were men. From baseline to 60 months, the mean systolic blood pressure increased by 10 center dot 4 mm Hg (95% CI 9 center dot 1-11 center dot 6) in the intervention group and 6 center dot 0 mm Hg (4 center dot 6-7 center dot 5) in the usual care group (adjusted mean difference 4 center dot 1 mm Hg [2 center dot 2 to 5 center dot 8]). Interpretation Lifestyle counselling and blood pressure monitoring by community health workers is effective in substantially reducing blood pressure while adults are being monitored in a trial but, following cessation of the intervention, this benefit is not maintained in the long term, with potential for harm. This finding could have important implications for funders and research communities to regularly target participants for education and follow-up at an optimal timepoint to reduce any likelihood of harm. Copyright (c) 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
引用
下载
收藏
页数:10
相关论文
共 19 条
  • [1] Effectiveness of a lifestyle intervention led by female community health volunteers versus usual care in blood pressure reduction (COBIN): an open-label, cluster-randomised trial
    Neupane, Dinesh
    McLachlan, Craig S.
    Mishra, Shiva Raj
    Olsen, Michael Hecht
    Perry, Henry B.
    Karki, Arjun
    Kallestrup, Per
    LANCET GLOBAL HEALTH, 2018, 6 (01): : E66 - E73
  • [2] Impact of a community health worker led intervention for improved blood pressure control in urban Nepal: an open-label cluster randomised controlled trial
    Bhattarai, Sanju
    Skovlund, Eva
    Shrestha, Archana
    Mjolstad, Bente Prytz
    Asvold, Bjorn Olav
    Sen, Abhijit
    LANCET REGIONAL HEALTH - SOUTHEAST ASIA, 2024, 29
  • [3] Sustainability of adalimumab in fistula healing and response: 2-year data from CHARM and 12-month open-label extension follow-up study
    Colombel, J. F.
    Kamm, M. A.
    Schwartz, D.
    Sandborn, W. J.
    Li, J.
    Lomax, K. G.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S497 - S498
  • [4] Endoscopic full-thickness plication for the treatment of GERD: 12-month follow-up for the North American open-label trial
    Pleskow, D
    Rothstein, R
    Lo, S
    Hawes, R
    Kozarek, R
    Haber, G
    Gostout, C
    Lembo, A
    GASTROINTESTINAL ENDOSCOPY, 2005, 61 (06) : 643 - 649
  • [5] 5-Year Follow-Up of a Telephone Intervention to Increase Fruit and Vegetable Consumption in Preschoolers: The 'Healthy Habits' Cluster Randomised Trial
    Wyse, Rebecca
    Stacey, Fiona
    Campbell, Libby
    Yoong, Serene
    Lecathelinais, Christophe
    Wiggers, John
    Campbell, Karen
    Wolfenden, Luke
    NUTRIENTS, 2020, 12 (12) : 1 - 15
  • [6] Sustained improvement in mild obstructive sleep apnoea by lifestyle intervention - post-interventional follow-up of a randomised, controlled trial (5-year follow-up upcoming)
    Tuomilehto, H.
    Uusitupa, M.
    Seppae, J.
    JOURNAL OF SLEEP RESEARCH, 2012, 21 : 91 - 91
  • [7] Effectiveness of a Female Community Health Volunteer-Delivered Intervention in Reducing Blood Glucose Among Adults With Type 2 Diabetes An Open-Label, Cluster Randomized Clinical Trial
    Gyawali, Bishal
    Sharma, Rajan
    Mishra, Shiva Raj
    Neupane, Dinesh
    Vaidya, Abhinav
    Sandbaek, Annelli
    Kallestrup, Per
    JAMA NETWORK OPEN, 2021, 4 (02) : E2035799
  • [8] Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
    Noh, Sung Hoon
    Park, Sook Ryun
    Yang, Han-Kwang
    Chung, Hyun Cheol
    Chung, Ik-Joo
    Kim, Sang-Woon
    Kim, Hyung-Ho
    Choi, Jin-Hyuk
    Kim, Hoon-Kyo
    Yu, Wansik
    Lee, Jong Inn
    Shin, Dong Bok
    Ji, Jiafu
    Chen, Jen-Shi
    Lim, Yunni
    Ha, Stella
    Bang, Yung-Jue
    LANCET ONCOLOGY, 2014, 15 (12): : 1389 - 1396
  • [9] Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial
    Haig, Ylva
    Enden, Tone
    Grotta, Ole
    Klow, Nils-Einar
    Slagsvold, Carl-Erik
    Ghanima, Waleed
    Sandvik, Leiv
    Hafsahl, Geir
    Holme, Pal Andre
    Holmen, Lars Olaf
    Njaaastad, Anne Mette
    Sandbaek, Gunnar
    Sandset, Per Morten
    LANCET HAEMATOLOGY, 2016, 3 (02): : E64 - E71
  • [10] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA): 5-YEAR FOLLOW-UP OF AN OPEN-LABEL TRIAL
    Ruperto, N.
    Brunner, H. I.
    Quartier, P.
    Constantin, T.
    Alexeeva, E.
    Schneider, R.
    Kone-Paut, I.
    Schikler, K.
    Marzan, K.
    Wulffraat, N.
    Padeh, S.
    Chasnyk, V.
    Wouters, C.
    Kuemmerle-Deschner, J. B.
    Kallinich, T.
    Lauwerys, B.
    Haddad, E.
    Nasonov, E.
    Trachana, M.
    Vougiouka, O.
    Leon, K.
    Speziale, A.
    Lheritier, K.
    Martini, A.
    Lovell, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 265 - 266